BINAGWAHO, Agnes et al. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ [online].
2012,
vol.90, n.8, pp. 623-628.
ISSN 0042-9686.
http://dx.doi.org/10.2471/BLT.11.097253.
|
|
2. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917. doi:10.1002/ijc.25516 PMID:21351269 [ Links ] 3. Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries – key challenges and issues. N Engl J Med 2007;356:1908–10. doi:10.1056/NEJMp078053 PMID:17494923 [ Links ] 4. Schiffman M, Wacholder S. Success of HPV vaccination is now a matter of coverage. Lancet Oncol 2012;13:10–2. doi:10.1016/S1470-2045(11)70324-2 PMID:22075169 [ Links ] 5. Ehreth J. The global value of vaccination. Vaccine 2003;21:596–600. doi:10.1016/S0264-410X(02)00623-0 PMID:12531324 [ Links ] 6. Raising the profile of pneumococcal disease: collaborations in communications efforts 2003–2008. Baltimore: PneumoADIP & GAVI; 2009. [ Links ] 7. Human papillomavirus (HPV) vaccine background paper. Geneva: World Health Organization; 2008. Available from: http://www.who.int/immunization/documents/HPVBGpaper_final_03_04_2009.pdf [accessed 4 April 2012] [ Links ] 8. Forouzanfar M, Foreman K, Delossantos A, Lozano R, Lopez A, Murray C et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011. Epub 14 Sept [ Links ] 9. World Health Organization [Internet]. Human papillomavirus and related cancers in Rwanda: summary report 2010. Geneva: WHO/ICO Information Centre on HPV and Cervical Cancer. Available from: www.who.int/hpvcentre [accessed 4 April 2012] [ Links ] 10. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011;89:821–30. doi:10.2471/BLT.11.08986 PMID:22084528 [ Links ] 11. National Strategic Plan for Prevention, Control, and Management of Cervical Lesions and Cancer. Kigali: Ministry of Health; 2010. [ Links ] 12. Rwanda Demographic and Health Survey 2005. Calverton: National Institute of Statistics of Rwanda & Macro International, Inc.; 2006. [ Links ] 13. Rwanda Demographic and Health Survey 2010. Calverton: National Institute of Statistics of Rwanda & Macro International, Inc.; 2012. [ Links ] 14. Price JE, Leslie JA, Welsh M, Binagwaho A. Integrating HIV clinical services into primary health care in Rwanda: a measure of quantitative effects. AIDS Care 2009;21:608–14. doi:10.1080/09540120802310957 PMID:19444669 [ Links ] 15. The AIDS response and the Millennium Development Goals: Rwanda case study. Geneva: Joint United Nations Programme for HIV/AIDS; 2010. [ Links ] 16. Ministry of Education of Rwanda [Internet]. Major achievements (2003–2010). Kigali: ME; 2011. Available from: http://www.mineduc.gov.rw/spip.php?article27 [ Links ] 17. Binagwaho A, Wagner CM, Nutt CT. HPV Vaccine in Rwanda: Different Disease, Same Double Standard. Lancet 2011;378:1916. doi:10.1016/S0140-6736(11)61837-0 PMID:22137840 [ Links ] 18. Hargreaves J, Greenwood B, Clift C, Goel A, Roemer-Mahler A, Smith R et al. Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines. Lancet 2011. Epub 9 June [ Links ] 19. GAVI Alliance [Internet]. GAVI welcomes lower prices for life-saving vaccines. Geneva: GAVI; 2011. Available from: http://www.gavialliance.org/library/news/press-releases/2011/gavi-welcomes-lower-prices-for-life-saving-vaccines/ [accessed 4 April 2012] [ Links ] |
